Navigation Links
ROX Medical enrolls first patients in Ireland for CONTROL-HTN hypertension trial at Beaumont and Mater Private Hospitals
Date:3/4/2013

SAN CLEMENTE, Calif., March 4, 2013 /PRNewswire/ -- ROX Medical announced enrollment of the first two Irish patients in the CONTROL-HTN randomized controlled trial of the ROX FLOW procedure for the treatment of resistant hypertension. Both patients were evaluated by hypertension specialists, Professor Alice Stanton , M.D. of Beaumont Hospital and Eamon Dolan , M.D. of Connolly Hospital in Dublin. One of the two patients was randomized to receive the ROX FLOW procedure, which was performed by Joseph Galvin , M.D. at The Mater Private Hospital, Dublin, Ireland. The minimally invasive procedure was performed in the cardiac catheter lab in less than one hour. The ROX procedure is a reversible therapy option for the management of resistant hypertension and may offer an alternative and/or concomitant therapy option to another increasingly popular hypertension procedure, renal denervation.

(Logo: http://photos.prnewswire.com/prnh/20130304/LA70984LOGO)

ROX Medical's FLOW procedure is a minimally invasive, catheter procedure whereby a small nitinol coupler is inserted between the artery and vein in the upper leg. The procedure reduces peripheral vascular resistance, thereby holding the promise of a meaningful long-term reduction in hypertension.  Uniquely, the FLOW procedure only involves the vascular structure, has an immediate effect; and is fully reversible.

"We congratulate the physicians at Beaumont, Connolly and Mater Private hospitals for their first successful enrollments in the CONTROL-HTN study", said ROX CEO Rodney Brenneman . "The ROX procedure is unique in providing a complimentary and/or alternative therapy option to the other major device approach, renal denervation", Brenneman said, "Device approaches are becoming accepted as important additional therapies physicians may employ for the thousands of uncontrolled hypertensive patients throughout the world".

The ROX FLOW procedure for hypertension is not approved for use in the U.S.


'/>"/>
SOURCE ROX Medical
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aquavit Pharmaceuticals Inc. Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer
2. Richard Wolf Medical Instruments Launches Narrow-Channel Reprocessing Training
3. Medical Alarm Concepts Provides Investor Update - Signs Deal with Health Care Insurance Provider for Medical Alarms
4. Medical Device Contract Manufacturing: World Market Outlook 2013-2023
5. SurgiCount Medical Launches New Surgical Sponge Product
6. Nonin Medical als exklusiver Anbieter für zerebrales/somatisches Oximetriesystems an führenden Kinderkliniken in Polen ausgewählt
7. Longitudinal Study Highlights Evolving Role of Medical Science Liaisons with Thought Leaders and Product Development
8. Accelovance Expands Oncology Leadership with the Addition of Ralph Boccia, MD as Oncology Medical Director
9. Nonin Medical Selected as Exclusive Provider of Cerebral/Somatic Oximetry Systems to Leading Pediatric Hospitals in Poland
10. Aethlon Medical (AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease & Cancer
11. GPMG Product Helps Medical Device Specification Developers be FDA and ISO 13485 Compliant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , January 18, 2017 Ximbio, ... to share research resources, has opened its first North American ... ... marks an expansion for Ximbio following its launch in October ... Research Technology (CRT), the commercialization arm of the foundation Cancer ...
(Date:1/18/2017)... , Jan. 18, 2017  Astellas Pharma Inc. ... ) today announced its participation in Access Accelerated, ... non-communicable disease (NCD) prevention, diagnostics and treatment in ... other leading pharmaceutical companies and in collaboration with ... International Cancer Control (UICC), Astellas will work towards ...
(Date:1/17/2017)... -- Secretary of Health Dr. Karen Murphy ... are warning Pennsylvanians of the potentially lethal risks ... the drug in Beaver County . ... animals and is not meant for humans – it ... it," Secretary Murphy said. "It,s absolutely essential that first ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health ... Peoples Health network on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage ... is an exciting addition to our provider network, and the addition will benefit ...
(Date:1/17/2017)... Houston, TEXAS (PRWEB) , ... January 17, 2017 ... ... solution provider, today announced its partnership with Sigfox in the U.S.A. ... to cities nationwide including new offerings on large-scale environmental sensor deployments such ...
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading audit, tax, ... in its IT Advisory Services practice . Rossi is the third technology consulting ... for strategic IT guidance grows, and the practice continues to expand.     , Bringing more ...
(Date:1/17/2017)... ... 17, 2017 , ... Physicians Education Review®, LCC (PER®) announces ... for the 34th Annual Miami Breast Cancer Conference®, on March 9-12, 2017 at ... Talamo, said, “We are delighted to have Sandra Lee join us as our ...
(Date:1/17/2017)... ... , ... Many people make New Year’s resolutions or renew their commitment to better health with ... for people who want to kick off 2017 with better smiles. Dr. Mondavi is offering ... special offers include: , , A new patient package for just ...
Breaking Medicine News(10 mins):